{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:55:32Z","timestamp":1781250932004,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/bf02931310","type":"journal-article","created":{"date-parts":[[2008,8,9]],"date-time":"2008-08-09T05:51:49Z","timestamp":1218261109000},"source":"Crossref","is-referenced-by-count":5,"title":["Treatment of orthopedic infections caused by resistant staphylococci"],"prefix":"10.1007","volume":"52","author":[{"given":"D.","family":"Jahoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Ny\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pokorn\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Landor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kr\u016fta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sosna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02931310_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jac\/dki016","volume":"55","author":"M. Bassetti","year":"2005","unstructured":"Bassetti M., Vitale F., Melica G., Righi E., Di Biagio A., Molfetta L., Pipino F., Cruciani M., Bassetti D.: Linezolid in treatment of Gram-positive prosthetic joint infections.J.Antimicrob.Chemother.\n                           55, 387\u2013390 (2005).","journal-title":"J.Antimicrob.Chemother."},{"key":"BF02931310_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF02931564","volume":"50","author":"Z. Brn\u00e1kov\u00e1","year":"2005","unstructured":"Brn\u00e1kov\u00e1 Z., Farka\u0161ovsk\u00e1 J., God\u00e1ny A.: The use of bacteriophages in eliminating polyresistant strains ofStaphylococcus aureus andStreptococcus agalactiae.Folia Microbiol.\n                           50, 187\u2013194 (2005).","journal-title":"Folia Microbiol."},{"key":"BF02931310_CR3","unstructured":"CDC (Centers for Disease Control and Prevention): MRSA \u2014 methicillin-resistantStaphylococcus aureus;http:\/\/www.cdc.gov\/ncidod\/hip\/Aresist\/MRSA.htm; CDC 2004."},{"issue":"Suppl. 4","key":"BF02931310_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1469-0691.2005.01162.x","volume":"11","author":"A.B. Cunha","year":"2005","unstructured":"Cunha A.B.: Methicillin-resistantS. aureus: clinical manifestation and antimicrobial therapy.Clin.Microbiol.Infect.\n                           11 (Suppl. 4), 33\u201342 (2005).","journal-title":"Clin.Microbiol.Infect."},{"key":"BF02931310_CR5","unstructured":"EARSS (European Antimicrobial Resistance Surveillance System): EARSS interactive database access. National Institute of Public Health and Environment, Bilthoven (The Netherlands) 2006;www.earss.rivm.nl."},{"key":"BF02931310_CR6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/S0140-6736(00)04376-2","volume":"358","author":"R.D. Gonzales","year":"2001","unstructured":"Gonzales R.D., Schreckenberger P.C., Graham M.B., Kelkar S., DenBesten K., Quinn J.P.: Infections due to vancomycin-resistantEnterococcus faecium resistant to linezolid.Lancet\n                           358, 1179 (2001).","journal-title":"Lancet"},{"key":"BF02931310_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1517\/14740338.3.5.405","volume":"3","author":"P.J. Harwood","year":"2004","unstructured":"Harwood P.J., Giannoudis P.V.: The safety and efficiency of linezolid in orthopedic practice for treatment of infection due to antibiotic-resistant organisms.Expert Opin.Drug Safety\n                           3, 405\u2013414 (2004).","journal-title":"Expert Opin.Drug Safety"},{"key":"BF02931310_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00068-004-1334-8","volume":"6","author":"J. Isenberg","year":"2004","unstructured":"Isenberg J., Prokop A., Seifert A., Jubel A.: Linezolid treatment of skeletal methicillin resistantStaphylococcus aureus infection.Eur.J.Trauma\n                           6, 387\u2013393 (2004).","journal-title":"Eur.J.Trauma"},{"key":"BF02931310_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/jmbi.1999.3247","volume":"294","author":"P. Kloss","year":"2001","unstructured":"Kloss P., Xiong L., Shinabarger D.L., Mankin A.S.: Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center.J.Mol.Biol.\n                           294, 93\u2013101 (2001).","journal-title":"J.Mol.Biol."},{"key":"BF02931310_CR10","first-page":"73","volume":"12","author":"M. Kol\u00e1\u0159","year":"2003","unstructured":"Kol\u00e1\u0159 M., \u010cekanov\u00e1 L., V\u00e1gnerov\u00e1 I.: Detection of vancomycin-resistant enterococci in community population living in the Czech Republic. (In Czech)Zpr\u00e1vy CEM\n                           12, 73\u201374 (2003).","journal-title":"Zpr\u00e1vy CEM"},{"key":"BF02931310_CR11","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1128\/AAC.47.12.3964-3966.2003","volume":"47","author":"F. Kutscha-Lissberg","year":"2003","unstructured":"Kutscha-Lissberg F., Hebler U., Muhr G., Koller M.: Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci.Antimicrob.Agents Chemother.\n                           47, 3964\u20133966 (2003).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931310_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/BF02932128","volume":"51","author":"P. Leszczy\u0144ski","year":"2006","unstructured":"Leszczy\u0144ski P., Weber-Dabrowska B., Kohutnicka M., Luczak M., G\u00f3recki A., G\u00f3rski A.: Successful eradication of methicillin-resistantStaphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker \u2014 case report.Folia Microbiol.\n                           51, 236\u2013239 (2006).","journal-title":"Folia Microbiol."},{"key":"BF02931310_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/jac\/dkf066","volume":"50","author":"A.M. Lovering","year":"2002","unstructured":"Lovering A.M., Zhang J., Bannister G.C., Lankester B.J., Brown J.H., Narendra G., MacGowan A.P.: Penetration of linezolid into bone, fat, muscle and hematoma of patients undergoing routine hip replacement.J.Antimicrob.Chemother.\n                           50, 73\u201377 (2002).","journal-title":"J.Antimicrob.Chemother."},{"key":"BF02931310_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1345\/aph.1D354","volume":"38","author":"I. Mogenet","year":"2004","unstructured":"Mogenet I., Raetz-Dillon S., Canonge J.-M., Archambaud M., Bonet E.: Successful treatment ofStaphylococcus epidermidis hip prosthesis infection with oral linezolid.Ann.Pharmacother.\n                           38, 986\u2013988 (2004).","journal-title":"Ann.Pharmacother."},{"key":"BF02931310_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/01.blo.0000144860.11193.5e","volume":"427","author":"N. Rao","year":"2004","unstructured":"Rao N., Ziran B.H., Hall R.A., Santa E.R.: Successful treatment of chronic bone and joint infections with oral linezolid.Clin.Orthoped.Relat.Res.\n                           427, 67\u201371 (2004).","journal-title":"Clin.Orthoped.Relat.Res."},{"key":"BF02931310_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s15010-004-3029-9","volume":"32","author":"C.R. Rayner","year":"2004","unstructured":"Rayner C.R., Baddour M.C., Birminham M.C., Norden A.K., Meagher A.K., Schentag J.J.: Linezolid in the treatment of osteomyelitis: results of compassionate use experience.Infection\n                           32, 8\u201314 (2004).","journal-title":"Infection"},{"key":"BF02931310_CR17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0025-6196(11)62596-2","volume":"79","author":"R.R. Razonable","year":"2004","unstructured":"Razonable R.R., Osmon D.R., Steckelberg J.M.: Linezolid therapy for orthopedic infections.Mayo Clin.Proc.\n                           79, 1137\u20131144 (2004).","journal-title":"Mayo Clin.Proc."},{"key":"BF02931310_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bmj.320.7229.213","volume":"320","author":"M.H. Reacher","year":"2000","unstructured":"Reacher M.H., Shah A., Livermore D.M., Wale M.C., Graham C., Johnson A.P., Heine H., Monnickendam M.A., Barker K.F., James D., Georgie R.C.: Bacteremia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis.Brit.Med.J.\n                           320, 213\u2013216 (2000).","journal-title":"Brit.Med.J."},{"key":"BF02931310_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/00001432-200312000-00001","volume":"16","author":"J.A. Shuford","year":"2003","unstructured":"Shuford J.A., Steckelberg J.M.: Role of antimicrobial therapy in the management of osteomyelitis.Curr.Opin.Infect.Dis.\n                           16, 515\u2013519 (2003).","journal-title":"Curr.Opin.Infect.Dis."},{"key":"BF02931310_CR20","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1128\/AAC.44.12.3408-3413.2000","volume":"44","author":"D.L. Stevens","year":"2000","unstructured":"Stevens D.L., Smith L.G., Bruss J.B., McConnell-Martin M.A., Duvall S.E., Todd W.M., Hafkin B.: Randomized comparison of linezolid (PNU-100766)versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections.Antimicrob.Agents Chemother.\n                           44, 3408\u20133413 (2000).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931310_CR21","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/AAC.42.12.3251","volume":"42","author":"S.M. Swaney","year":"1998","unstructured":"Swaney S.M., Aoki H., Ganoza M.C., Shinabarger D.L.: The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria.Antimicrob.Agents Chemother.\n                           42, 3251\u20133255 (1998).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931310_CR22","first-page":"185","volume":"6","author":"A. Trampuz","year":"2005","unstructured":"Trampuz A., Zimmerli W.: New strategies for the treatment of infections associated with prosthetic joints.Curr.Opin.Investig.Drugs\n                           6, 185\u2013190 (2005).","journal-title":"Curr.Opin.Investig.Drugs"},{"key":"BF02931310_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","volume":"358","author":"S. Tsiodras","year":"2001","unstructured":"Tsiodras S., Gold H.S., Sakoulas G., Eliopoulos G.M., Wennersten C., Venkataraman L., Moelering R.C., Ferraro M.J.: Linezolid resistance in a clinical isolate ofStaphylococcus aureus.Lancet\n                           358, 207\u2013208 (2001).","journal-title":"Lancet"},{"key":"BF02931310_CR24","first-page":"296","volume":"13","author":"P. Urb\u00e1\u0161kov\u00e1","year":"2004","unstructured":"Urb\u00e1\u0161kov\u00e1 P., Mackov\u00e1 B., Melter O.: Cefoxitin disks \u2014 confidential method for detection of oxacillin-resistant staphylococci strains. (In Czech)Zpr\u00e1vy CEM\n                           13, 296\u2013297 (2004).","journal-title":"Zpr\u00e1vy CEM"},{"key":"BF02931310_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/BF02931580","volume":"51","author":"E. Walencka","year":"2006","unstructured":"Walencka E., Sadowska B., R\u00f3\u017calska S., Hryniewicz W., R\u00f3\u017calska B.:Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and\/or lysostaphin.Folia Microbiol.\n                           51, 381\u2013386 (2006).","journal-title":"Folia Microbiol."},{"key":"BF02931310_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.amjsurg.2004.08.045","volume":"188","author":"J. Weigelt","year":"2004","unstructured":"Weigelt J., Kaafarani H.M., Itani K.M., Swanson R.N.: Linezolid eradicates MRSA better than vancomycin from surgical-site infections.Am.J.Surg.\n                           188, 760\u2013766 (2004).","journal-title":"Am.J.Surg."},{"key":"BF02931310_CR27","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","volume":"49","author":"J. Weigelt","year":"2005","unstructured":"Weigelt J., Itani K., Stevens D., Lau W., Dryden M., Knirech C.: Linezolidvs. vancomycin in the treatment of complicated skin and soft tissue infections.Antimicrob.Agents Chemother.\n                           49, 2260\u20132266 (2005).","journal-title":"Antimicrob.Agents Chemother."},{"key":"BF02931310_CR28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/clind\/24.4.584","volume":"24","author":"M.P. Weinstein","year":"1997","unstructured":"Weinstein M.P., Towns M.L., Quartey S.M., Mirrett S., Reimer L.G., Parmigiani G., Reller L.B.: The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.Clin.Infect.Dis.\n                           24, 584\u2013602 (1997).","journal-title":"Clin.Infect.Dis."}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02931310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02931310\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02931310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02931310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T05:13:02Z","timestamp":1652677982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02931310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["BF02931310"],"URL":"https:\/\/doi.org\/10.1007\/bf02931310","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]},"article-number":"281"}}